Structure Therapeutics has touted the 16% weight loss—about 39 pounds—seen by aleniglipron as the best results yet for an oral GLP-1 drug, as the obesity biotech readies the candidate for phase 3. The ...

SAN DIEGO--(BUSINESS WIRE)--SEQSTER PDM, Inc. (“SEQSTER”), the leading healthcare technology company and the data connection, collection, and orchestration layer for patient health data, today ...

Abstract: Data Structures and Algorithms (DSA) is fundamental to computer science education, yet novice learners face significant challenges in grasping abstract concepts and their system-level ...

TikTok's US app has been glitchy for days as it faces issues tied to a Oracle data center outage. Users have reported seeing a flurry of old videos in their feeds and 0 views on new uploads. The ...

Elon Musk's social network X (formerly known as Twitter) last night released some of the code and architecture of its overhauled social recommendation algorithm under a permissive, enterprise-friendly ...

Low-rank data analysis has emerged as a powerful paradigm across applied mathematics, statistics, and data science. With the rapid growth of modern datasets in size, dimensionality, and complexity, ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Amid an outpouring of obesity data Monday, Wave Life Sciences and Structure Therapeutics were among the biotechs jockeying to set their weight loss assets apart in an increasingly crowded field as ...

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...

SAN FRANCISCO, Oct 22 (Reuters) - Google said it has developed a computer algorithm that points the way to practical applications for quantum computing and will be able to generate unique data for use ...